Cost-Effectiveness of Recently Approved Gene and Cell Therapies for Ultra-Rare Pediatric Disorders: Implications for Genomic Medicine and Expanded Newborn Screening

Genetics in Medicine Open · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles